generics
-
News
Häusermann (Assogenerici): “Grateful to the pharmacists for spreading the culture of generics”. Ed
The equivalent drug industry recognizes a great merit to pharmacies, namely that of having 'educated' the…
Leggi » -
News
Assogenerics. "Pure" generics absorb 21.5% in units and 12.4% in pharmacy channel values
Another year of growth for the generic drug market which in 2017 absorbed 21.5% per pack…
Leggi » -
News
Agreement on regional autonomy. Decisions based on the therapeutic equivalence of medicines are expected to be taken
Autonomy agreements for Veneto, Lombardy and Emilia: requests on equivalents and direct distribution 02/03/2018 – Federfarma Signed at Palazzo…
Leggi » -
News
USA. Generic drug costs 28 times more than the patented one
Il medicinale è usato per la malattia di Wilson NEW YORK – Anche i farmaci generici possono avere costi spropositati.…
Leggi » -
News
From equivalent and biosimilars valuable resources for innovation but possible distorting effects
Accesso alle terapie e sostenibilità: da equivalenti e biosimilari risorse preziose per l’innovazione farmaceutica AIFA Editorial – 23/02/2018 La diffusione…
Leggi » -
News
Active ingredients Italian primacy to be defended
Tutti i numeri di un settore da 3,6 mld euro L’industria dei principi attivi farmaceutici si conferma un settore manifatturiero…
Leggi » -
First floor
Switch to biosimilar drugs, ANMAR reports the continuous violations of the law to the public prosecutor's office
ANMAR denounced with a letter to the Public Prosecutor's Office at the court of Florence the continuous violations of the Law…
Leggi » -
News
Indians point to generics from Sanofi
Sanofi plans to divest Zentiva's generics business by the end of the year. The decision appeals to large Asian multinationals…
Leggi » -
News
La Regione Piemonte risparmierà 15 milioni col generico rosuvastatina
LA REGIONE RISPARMIA 15 MILIONI SULLA FARMACEUTICA mercoledì 10 gennaio 2018 IL FARMACO PER IL COLESTEROLO COSTA IL 75% IN…
Leggi » -
News
Teva cuts but the workers are not there.
Un colosso farmaceutico in crisi Foro di Roma – 18 dicembre 2017 – da Redazione Era una delle storie di…
Leggi »